[1]
Magnuson, J.S.; Henry, J.F.; Yip, T.T.; Hutchens, T.W. Structural homology of human, bovine, and porcine milk lactoferrins: Evidence for shared antigenic determinants. Pediatr. Res., 1990, 28, 176-181.
[2]
Lönnerdal, B.; Jiang, R.; Du, X. Bovine lactoferrin can be taken up by the human intestinal lactoferrin receptor and exert bioactivities. J. Pediatr. Gastroenterol. Nutr., 2011, 53, 606-614.
[3]
Anderson, B.F.; Baker, H.M.; Norris, G.E.; Rumball, S.V.; Baker, E.N. Apolactoferrin structure demonstrates ligand-induced conformational change in transferrins. Nature, 1990, 344, 784-787.
[4]
Luis Moreno-Expósitoa, L.; Illescas-Montesb, R.; Melguizo-Rodrígueza, L.; Ruiza, C.; Ramos-Torrecillasa, J.; de Luna-Bertosa, E. Multifunctional capacity and therapeutic potential of lactoferrin. Life Sci., 2018, 196, 61-64.
[5]
Brock, J.H. Lactoferrin – 50 years on. Biochem. Cell Biol., 2012, 90, 245-251.
[6]
Drago-Serrano, M.E.; Campos-Rodríguez, R.; César Carrero, J.; de la Garza, M. Lactoferrin: Balancing ups and downs of inflammation due to microbial infections. Int. J. Mol. Sci., 2017, 18, 501.
[7]
Rosa, L.; Cutone, A.; Lepanto, M.S.; Paesano, R.; Valenti, P. Lactoferrin: A natural glycoprotein involved in iron and inflammatory homeostasis. Int. J. Mol. Sci., 2017, 18, 1985.
[8]
Aisen, P.; Leibman, A. Lactoferrin and transferrin: A comparative study. Biochim. Biophys. Acta Protein Struct., 1972, 257, 314-323.
[9]
Anderson, B.F.; Baker, H.M.; Norris, G.E.; Rice, D.W.; Baker, E.N. Structure of human lactoferrin: Crystallographic structure analysis and refinement at 2.8 A resolution. J. Mol. Biol., 1989, 209, 711-734.
[10]
Troost, F.J.; Steijns, J.; Saris, W.H.M.; Brummer, R.J.M. Gastric digestion of bovine lactoferrin in vivo in adults. J. Nutr., 2001, 131, 2101-2104.
[11]
Baker, H.M.; Baker, E.N. A structural perspective on lactoferrin function. Biochem. Cell Biol., 2012, 90, 320-328.
[12]
Chilton, C.H.; Crowther, G.S.; Śpiewak, K.; Brindell, M.; Singh, G.; Wilcox, M.H.; Monaghan, T.M. Potential of lactoferrin to prevent antibiotic-induced Clostridium difficile infection. J. Antimicrob. Chemother., 2016, 71(4), 975-985.
[13]
Kanwar, J.R.; Mahidhara, G.; Kanwar, R.K. Novel alginate-enclosed chitosan-calcium phosphate-loaded iron-saturated bovine lactoferrin nanocarriers for oral delivery in colon cancer therapy. Nanomedicine (Lond.), 2012, 7, 1521-1550.
[14]
Kanwar, J.R.; Palmano, P.K.; Sun, X.; Kanwar, R.K.; Gupta, R.; Haggarty, N. “Iron saturated” lactoferrin is a potent natural adjuvant for augmenting cancer chemotherapy. Immunol. Cell Biol., 2008, 86, 277-288.
[15]
Kanwar, R.K.; Kanwar, J.R. Immunomodulatory lactoferrin in the regulation of apoptosis modulatory proteins in cancer. Protein Pept. Lett., 2013, 20, 450-458.
[16]
Samarasinghe, R.M.; Kanwar, R.K.; Kanwar, J.R. The effect of oral administration of iron saturated-bovine lactoferrin encapsulated chitosan-nanocarriers on osteoarthritis. Biomaterials, 2014, 35, 7522-7534.
[17]
Ainscough, E.W.; Brodie, A.M.; Plowman, J.E. The chromium, manganese, cobalt, and copper complexes of human lactoferrin. Inorg. Chim. Acta, 1979, 33, 149-153.
[18]
Lew, L.C.; Liong, M.T.; Gan, C.Y. Growth optimization of Lactobacillus rhamnosus FTDC 8313 and the production of putative dermal bioactives in the presence of manganese and magnesium ions. J. Appl. Microbiol., 2013, 114(2), 526-535.
[19]
Lönnerdal, B.; Keen, C.L.; Hurley, L.S. Manganese binding proteins in human and cow’s milk. Am. J. Clin. Nutr., 1985, 41, 550-559.
[20]
Marchetti, M.; Superti, F.; Ammendolia, M.G.; Rossi, P.; Valenti, P.; Seganti, L. Inhibition of poliovirus type 1 infection by iron-, manganese and zinc saturated lactoferrin. Med. Microbiol. Immunol., 1999, 187(4), 199-204.
[21]
Superti, F.; Siciliano, R.; Rega, B.; Giansanti, F.; Valenti, P.; Antonini, G. Involvement of bovine lactoferrin metal saturation, sialic acid and protein fragments in the inhibition of rotavirus infection. Biochim. Biophys. Acta, 2001, 1528(2-3), 107-115.
[22]
Pietrantoni, A.; Ammendolia, M.G.; Superti, F. Bovine lactoferrin: Involvement of metal saturation and carbohydrates in the inhibition of influenza virus infection. Biochem. Cell Biol., 2012, 90(3), 442-448.
[23]
Śpiewak, K.; Majka, G.; Pilarczyk-Żurek, M.; Nowak, P.M.; Woźniakiewicz, M.; Pietrzyk, P.; Korzeniak, T.; Stochel-Gaudyn, A.; Fyderek, K.; Strus, M.; Brindell, M. Mn3+-saturated bovine lactoferrin as a new complex with potential prebiotic activities for dysbiosis treatment and prevention – On the synthesis, chemical characterization and origin of biological activity. J. Funct. Foods, 2017, 38, 264-272.
[24]
Majka, G.; Więcek, G.; Śróttek, M.; Śpiewak, K.; Brindell, M.; Koziel, J.; Marcinkiewicz, J.; Strus, M. The impact of lactoferrin with different levels of metal saturation on the intestinal epithelial barrier function and mucosal inflammation. BioMetals, 2016, 29(6), 1019-1033.
[25]
Takeuchi, T.; Jyonotsuka, T.; Kamemori, N.; Kawano, G.; Shimizu, H.; Ando, K.; Harada, E. Enteric-formulated lactoferrin was more effectively transported into blood circulation from gastrointestinal tract in adult rats. Exp. Physiol., 2006, 91, 1033-1040.
[26]
Hejazi, R.; Amiji, M. Chitosan-based gastrointestinal delivery systems. J. Control. Release, 2003, 89, 151-165.
[27]
Onishi, H.; Machida, Y.; Koyama, K. Preparation and in vitro characteristics of lactoferrin loaded chitosan microparticles. Drug Dev. Ind. Pharm., 2007, 33, 641-647.
[28]
Onishi, H.; Koyama, K.; Sakata, O.; Machida, Y. Preparation and in vitro evaluation of chitosan-coated alginate/calcium complex microparticles loaded with fluorescein-labeled lactoferrin. Yakugaku Zasshi, 2009, 129, 1507-1514.
[29]
Kilic, E.; Novoselova, M.V.; Hui Lim, S.; Pyataev, N.A.; Pinyaev, S.I.; Kulikov, O.A.; Sindeeva, O.A.; Mayorova, O.A.; Murney, R.; Antipina, M.N.; Haigh, B.; Sukhorukov, G.B.; Kiryukhin, M.V. Formulation for oral delivery of lactoferrin based on bovine serum albumin and tannic acid multilayer microcapsules. Sci. Rep., 2017, 7, 44159.
[30]
Yao, X.; Bunt, C.; Cornish, J.; Quek, S.Y.; Wen, J. Oral delivery of lactoferrin: A review. Int. J. Pept. Res. Ther., 2013, 19, 125-134.
[31]
Onishi, H. Lactoferrin delivery systems: Approaches for its more effective use. Expert Opin. Drug Deliv., 2011, 8, 1469-1479.
[32]
Monaghan, T.; Braim, S.; Spiewak, K.; Brindell, M.; Alexander, C. Novel lactoferrin-loaded alginate microbeads sisplay anti-Clostridium difficile defence properties. Gut, 2018, 61(Suppl. 1), A194-A195.